We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
Cap. Flow
+$236M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.93B
2
KVUE icon
Kenvue
KVUE
+$537M
3
HUM icon
Humana
HUM
+$477M
4
ABBV icon
AbbVie
ABBV
+$441M
5
MSFT icon
Microsoft
MSFT
+$384M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$747M
2
AAPL icon
Apple
AAPL
+$565M
3
ATVI
Activision Blizzard
ATVI
+$467M
4
MCK icon
McKesson
MCK
+$347M
5
INTC icon
Intel
INTC
+$300M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 17.06%
3 Consumer Discretionary 12.96%
4 Consumer Staples 7.45%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVLT icon
501
Commault Systems
CVLT
$5.89B
$15.1M 0.03%
223,336
+13,774
+7% +$977K
EWT icon
502
iShares MSCI Taiwan ETF
EWT
$10B
$15M 0.03%
337,133
+228,466
+210% +$10.6M
GSL icon
503
Global Ship Lease
GSL
$1.57B
$15M 0.03%
818,008
-188,079
-19% -$3.67M
LEVI icon
504
Levi Strauss
LEVI
$9.44B
$15M 0.03%
1,103,051
-245,663
-18% -$3.43M
TXNM
505
TXNM Energy Inc
TXNM
$6.47B
$14.9M 0.03%
334,549
+31,131
+10% +$1.39M
PCRX icon
506
Pacira BioSciences
PCRX
$1.02B
$14.9M 0.03%
485,645
+97,348
+25% +$3.51M
CLDX icon
507
Celldex Therapeutics
CLDX
$2.77B
$14.8M 0.03%
538,319
+248,796
+86% +$7.8M
XLK icon
508
PUT
State Street Technology Select Sector SPDR ETF
XLK
$115B
$14.8M 0.03%
180,600
-58,400
-24% -$5.01M
VRDN icon
509
Viridian Therapeutics
VRDN
$2.13B
$14.8M 0.03%
962,493
+311,314
+48% +$5.94M
DY icon
510
Dycom Industries
DY
$12.9B
$14.7M 0.03%
165,573
-571
-0.3% -$57K
CASY icon
511
Casey's General Stores
CASY
$31.9B
$14.7M 0.03%
+54,218
New +$13.7M
SILK
512
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$14.7M 0.03%
977,961
-123,742
-11% -$2.57M
SCHG icon
513
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
$14.6M 0.03%
802,460
+721,200
+888% +$13.6M
BLBD icon
514
Blue Bird Corp
BLBD
$2.41B
$14.6M 0.03%
683,020
+52,381
+8% +$1.11M
O icon
515
Realty Income
O
$61.2B
$14.5M 0.03%
290,494
-689,544
-70% -$39.6M
INFN
516
DELISTED
Infinera Corporation Common Stock
INFN
$14.4M 0.03%
3,452,680
+1,486,498
+76% +$6.42M
JACK icon
517
Jack in the Box
JACK
$278M
$14.4M 0.03%
208,961
-132,232
-39% -$11.3M
XOP icon
518
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
$14.3M 0.03%
+96,800
New +$13.9M
NCLH icon
519
Norwegian Cruise Line
NCLH
$8.89B
$14.3M 0.03%
868,329
+574,233
+195% +$10.6M
INSM icon
520
Insmed
INSM
$23.2B
$14.3M 0.03%
565,763
+119,549
+27% +$2.73M
SLV icon
521
PUT
iShares Silver Trust
SLV
$28.1B
$14.3M 0.03%
701,200
+603,500
+618% +$13M
BSBR icon
522
Santander
BSBR
$39.7B
$14.3M 0.03%
2,779,942
-31,545
-1% -$179K
ALGN icon
523
Align Technology
ALGN
$12B
$14.3M 0.03%
+46,694
New +$16.1M
ARW icon
524
Arrow Electronics
ARW
$10.9B
$14.1M 0.03%
+112,393
New +$15M
IMAX icon
525
IMAX
IMAX
$2.38B
$14M 0.03%
723,586
+622,014
+612% +$11.5M
19 20
21
22 23

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q3 2023 Portfolio in Review

As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
  • Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
  • Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
  • Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
  • Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
  • Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.